A randomised clinical trial of radiotherapy plus cisplatin versus radiotherapy alone in stage III non-small cell lung cancer

Lung Cancer

Volumn 43, Issue 3, 2004, Pages 309-316

  Cakir, Saban ^a   Egehan, Ibrahim ^b  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Cisplatin; Non small cell lung cancer; Radiosensitizer; Radiotherapy

Indexed keywords

CISPLATIN; HEMOGLOBIN;

ACUTE TOXICITY; ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHRONIC TOXICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; ESOPHAGITIS; FEMALE; HUMAN; HUMAN TISSUE; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NAUSEA; NEPHROTOXICITY; PNEUMONIA; PRIORITY JOURNAL; PROBABILITY; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SURVIVAL RATE; TIME; VOMITING;

EID: 1242328770     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2003.09.009     Document Type: Article

References (22)

1. Perez C.A., Pajak T., Rubin P., Simpson J.R., Mohiuddin M., Brady L.W., Perez-Tamayo R., Rotman M. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Cancer. 59:1987;1874-1881.
2. Schaake-Koning C., Van den Bogaert W., Dalesio O., Festen J., Hoogenhout J., van Houtte P., Kirkpatrick A., Koolen M., Maat B., Nijs A. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N. Engl. J. Med. 326:1992;524-530.
3. Dillman RO, Seagren SL, Propert KJ, Guerra J, Eaton WL, Perry MC, Carey RW, Frei EF 3rd, Green MR. A randomized trial of induction chemotherapy high-dose radiation versus radiation alone in stage III non-small cell lung cancer. N Engl J Med 1990;323:940-45.
4. Le Chevalier T., Arriagada R., Quoix E., Ruffie P., Martin M., Tarayre M., Lacombe-Terrier M-J., Douillard J-Y., Laplanche A. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small cell lung cancer. J. Natl. Cancer Inst. 83:1991;417-423.
5. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 1995;311:899-909.
6. Bartelink H., Kallman R.F., Rapacchiette D., Hart G.A. Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cisdiammine dichloroplatinum(II) and irradiation. Radiother. Oncol. 6:1986;61-74.
7. Dewit L. Combined treatment radiation and cisdiamminedichloro- platinum(II): areview of experimental and clinical data. Int. J. Radiat. Oncol. Biol. Phys. 13:1987;403-426.
8. Stell G.G. The search for therapeutic gain in the combination of radiotherapy and chemotherapy. Radiother. Oncol. 1:1988;31-33.
9. Von der Maase H., Overgaard J., Vaeth M. Effect of cancer chemotherapeutic drugs on radiation-induced lung damage in mice. Radiother. Oncol. 5:1986;245-257.
10. UICC (International Union Against Cancer). TNM classification of malignant tumours. Berlin: Springer Verlag; 1987. p. 69-73.
11. World Health Organisation handbook for reporting results of cancer treatment (WHO offset publication). Geneva, Switzerland: World Health Organisation; 1979.
12. Soresi E., Clerici M., Grilli R., Borghini U., Zucali R., Leoni M., Botturi M., Vergari C., Luporini G., Scoccia S. A randomized clinical trial comparing radiation therapy v radiation therapy plus cis- dichlorodiammineplatinum(II) in treatment of locally advanced non-small cell lung cancer. Semin. Oncol. 15(Suppl 7):1988;20-25.
13. Trovo M.G., Minatel E., Franchin G., Boccleri M.G., Nascimben O., Bolzicco G., Pizzi G., Torretta A., Veronesi A., Gobitti C. Radiotherapy versus radioherapy enhanced by cisplatin in stage III non-small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 24:1992;11-15.
14. Blanke C., Ansari R., Mantravadi R., Gonin R., Tokars R., Fisher W., Pennington K., O'Connor T., Rynard S., Miller M. Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small cell lung cancer: a Hoosier Oncology Group protocol. J. Clin. Oncol. 13(6):1995;1425-1429.
15. Keys H.M., Bundy B.N., Stehman F., Muderspach L.I., Chafe W.E., Suggs C.L. 3rd, Walker J.L., Gersell D. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N. Engl. J. Med. 340:1999;1154-1161.
16. Morris M., Eifel P.I., Lu J., Grigsby P.W., Levenback C., Stevens R.E., Rotman M., Gershenson D.M., Mutch D.G. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high risk cervical cancer. N. Engl. J. Med. 340:1999;1137-1143.
17. Rose P.C., Bundy B.N., Watkins E.B., Thigpen J.T., Deppe G., Maiman M.A., Clarke-Pearson D.L., Insalaco S. Concurrent cisplatin based radiotherapy and chemotherapy for locally advanced cervical cancer. N. Engl. J. Med. 340:1999;1144-1153.
18. Calais G., Alfonsi M., Bardet E., Sire E., Germain T., Bergerot P., Rhein B., Tortochaux J., Oudinot P., Bertrand P. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharinx carcinoma. J. Natl. Cancer Inst. 91:1999;2081-2086.
19. Bernier J., Bentzen S.M. Altered fractionation and combined radio-chemotherapy approaches: pioneering new opportunities in head and neck cancer oncology. Eur. J. Cancer. 39(3):2003;560-571.
20. Jeremic B., Shibamoto Y., Acimovic L., Milisavljevic S. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small cell lung cancer: a randomized study. J. Clin. Oncol. 14:1996;1065-1070.
21. Furuse K., Fukuoka M., Kawahara M., Nishikawa H., Takada Y., Kudoh S., Katagami N., Ariyoshi Y. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small cell lung cancer. J. Clin. Oncol. 17:1999;2692-2699.
22. Bartelink H., Schellens J.H.M., Verheij M. The combined use of radiotherapy and chemotherapy in the treatment of solid tumours. Eur. J. Cancer. 38:2002;216-222.